BIND Therapeutics to Present at JMP Securities Life Sciences Conference 2015

World News: . []

BIND Therapeutics Inc NASDAQ BIND a clinical-stage nanomedicine company developing LINK  and programmable therapeutics called AccurinsTM announced today that LINK  Hirsch BINDs president and chief LINK  office...

More news and information about BIND Therapeutics, Inc.

Published By:

Business Wire: 13:00 GMT Tuesday 16th June 2015

Published: .

Search for other references to "bind" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us